• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

REVA Medical

edit

Founded in 1998, REVA Medical is dedicated to developing minimally invasive medical devices that leverage the Company’s proprietary biomaterial and stent technologies to improve the treatment of disease. Guided by a management team and scientific advisors with extensive product development and clinical interventional cardiology experience, REVA’s initial focus is the development of an innovative drug-eluting bioresorbable coronary stent and the commencement of clinical studies that will advance the treatment of coronary artery disease.

Recent Milestones

edit

• 
  REVA Medical — REVA Medical's Australian IPO Beats Elevated Expectations (12/22/10)
  Posted 12/29/10 at 6:31pm via dowjones.com
• 
  REVA Medical added Robert Schultz as President and COO.
  Posted 12/29/10 at 6:29pm
• 
  REVA Medical added Robert Stockman as CEO.
  Posted 12/29/10 at 6:29pm
• 
  REVA Medical added Katrina Thompson as CFO and Corporate Secretary.
  Posted 12/29/10 at 6:29pm

Videos

Screenshots

edit

Sources

REVA Medical's Australian IPO Beats Elevated Expectations (fis.dowjones.com) [edit]